Skip Nav Destination
Issues
15 May 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Cancer Research
Table of Contents
Reviews
Priority Reports
Molecular Biology, Pathobiology, and Genetics
An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown Origin
Richard W. Tothill; Adam Kowalczyk; Danny Rischin; Alex Bousioutas; Izhak Haviv; Ryan K. van Laar; Paul M. Waring; John Zalcberg; Robyn Ward; Andrew V. Biankin; Robert L. Sutherland; Susan M. Henshall; Kwun Fong; Jonathan R. Pollack; David D.L. Bowtell; Andrew J. Holloway
YB-1 Provokes Breast Cancer through the Induction of Chromosomal Instability That Emerges from Mitotic Failure and Centrosome Amplification
Stephan Bergmann; Brigitte Royer-Pokora; Ellen Fietze; Karsten Jürchott; Barbara Hildebrandt; Detlef Trost; Frauke Leenders; Jenny-Chang Claude; Franz Theuring; Ralf Bargou; Manfred Dietel; Hans-Dieter Royer
Association of DNA Methylation of Phosphoserine Aminotransferase with Response to Endocrine Therapy in Patients with Recurrent Breast Cancer
John W.M. Martens; Inko Nimmrich; Thomas Koenig; Maxime P. Look; Nadia Harbeck; Fabian Model; Antje Kluth; Joan Bolt-de Vries; Anieta M. Sieuwerts; Henk Portengen; Marion E. Meijer-Van Gelder; Christian Piepenbrock; Alexander Olek; Heinz Höfler; Marion Kiechle; Jan G.M. Klijn; Manfred Schmitt; Sabine Maier; John A. Foekens
Cell and Tumor Biology
Transforming Growth Factor-β Suppresses Nonmetastatic Colon Cancer through Smad4 and Adaptor Protein ELF at an Early Stage of Tumorigenesis
Yi Tang; Varalakshmi Katuri; Radhika Srinivasan; Franz Fogt; Robert Redman; Girish Anand; Anan Said; Thomas Fishbein; Michael Zasloff; E. Premkumar Reddy; Bibhuti Mishra; Lopa Mishra
HER2 Overexpression Increases Sensitivity to Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, through Inhibition of HER2/HER3 Heterodimer Formation in Lung Cancer Cells
Akira Hirata; Fumihito Hosoi; Miho Miyagawa; Shu-ichi Ueda; Seiji Naito; Teruhiko Fujii; Michihiko Kuwano; Mayumi Ono
Stimulation of Mitochondrial Activity by p43 Overexpression Induces Human Dermal Fibroblast Transformation
Stéphanie Grandemange; Pascal Seyer; Angel Carazo; Philippe Bécuwe; Laurence Pessemesse; Muriel Busson; Cécile Marsac; Pascal Roger; François Casas; Gérard Cabello; Chantal Wrutniak-Cabello
α-Melanocortin and Endothelin-1 Activate Antiapoptotic Pathways and Reduce DNA Damage in Human Melanocytes
Ana Luisa Kadekaro; Renny Kavanagh; Hiromi Kanto; Silva Terzieva; Jennifer Hauser; Nobuhiko Kobayashi; Sandy Schwemberger; James Cornelius; George Babcock; Howard G. Shertzer; Glynis Scott; Zalfa A. Abdel-Malek
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Treatment of Chemotherapy-Resistant Human Ovarian Cancer Xenografts in C.B-17/SCID Mice by Intraperitoneal Administration of Clostridium perfringens Enterotoxin
Alessandro D. Santin; Stefania Cané; Stefania Bellone; Michela Palmieri; Eric R. Siegel; Maria Thomas; Juan J. Roman; Alexander Burnett; Martin J. Cannon; Sergio Pecorelli
AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer
Stephen R. Wedge; Jane Kendrew; Laurent F. Hennequin; Paula J. Valentine; Simon T. Barry; Sandra R. Brave; Neil R. Smith; Neil H. James; Michael Dukes; Jon O. Curwen; Rosemary Chester; Janet A. Jackson; Sarah J. Boffey; Lyndsey L. Kilburn; Sharon Barnett; Graham H.P. Richmond; Peter F. Wadsworth; Mike Walker; Alison L. Bigley; Sian T. Taylor; Lee Cooper; Sarah Beck; Juliane M. Jürgensmeier; Donald J. Ogilvie
The Human Multidrug Resistance Protein MRP5 Transports Folates and Can Mediate Cellular Resistance against Antifolates
Peter Wielinga; Jan Hendrik Hooijberg; Sjofn Gunnarsdottir; Ietje Kathmann; Glen Reid; Noam Zelcer; Kasper van der Born; Marcel de Haas; Ingrid van der Heijden; Gertjan Kaspers; Jan Wijnholds; Gerrit Jansen; Godefridus Peters; Piet Borst
Milk Thistle and Prostate Cancer: Differential Effects of Pure Flavonolignans from Silybum marianum on Antiproliferative End Points in Human Prostate Carcinoma Cells
Paula R. Davis-Searles; Yuka Nakanishi; Nam-Cheol Kim; Tyler N. Graf; Nicholas H. Oberlies; Mansukh C. Wani; Monroe E. Wall; Rajesh Agarwal; David J. Kroll
Immunology
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds